Improving emotional and psychosexual wellbeing screening in women living with polycystic ovary syndrome: experiences from the United Kingdom and India

With increasing evidence of emotional well-being disorders associated with polycystic ovary syndrome (PCOS), effective screening processes are of utmost importance. We studied the impact of using questionnaires to screen for emotional and psychosexual well-being across different models of care for PCOS. We analysed the data from the surveys to assess the difference in the prevalence of emotional and psychosexual well-being across ethnicity and region. In this prospective cohort study, we invited all women attending consultations for PCOS in Birmingham, UK, Bengaluru, and Navi Mumbai, India. Those who consented to participate in the study were invited to complete a pre-clinic survey about socio-demographic data, Hospital Anxiety and Depression Scale (HADS), Body Image Concern Inventory (BICI), Beliefs about Obese Person scale (BAOP), and Female Sexual Function Index score (FSFI) and a post-clinic survey on clinic experience, lifestyle advice and specialist referral. A total of 115 women were included in this study. The rate of questionnaire completion was 98.3% (113/115), 97.4% (112/115), 93.04% (107/115), and 84.3% (97/115) for HADS, BICI, BAOP and FSFI, respectively. In the post-clinic survey, 28.8% reported they were screened for anxiety, 27.1% for depression, and 45.8% for body image concerns. The prevalence of anxiety, depression and body dysmorphic disorder through pre-clinic survey was 56.5% (50.0% UK vs 59.5% India, p=.483), 16.5% (13.9% UK vs 17.7% India, p=.529), and 29.6% (36.1% UK vs 26.6% India, p=.208) respectively. Surveys with validated questionnaires can improve screening for emotional and psychosexual well-being associated with PCOS, which may be missed by ad hoc screening during consultations.